Binding proteins from alternative scaffolds

Journal of Immunological Methods

Volumn 290, Issue 1-2, 2004, Pages 3-28

  Nygren, Per Åke ^a   Skerra, Arne ^b  

^a ALBANOVA UNIVERSITY CENTER   (Sweden)

^b TECHNICAL UNIVERSITY OF MUNICH   (Germany)

Author keywords

Antibody; CDR; Combinatorial biochemistry; complementarity determining region; dissociation constant; Ig; immunoglobulin; KD; Library selection; Molecular recognition; PCR; polymerase chain reaction; Protein engineering; VH

Indexed keywords

BINDING PROTEIN;

CYTOPLASM; GENE CONSTRUCT; GENE LIBRARY; PRIORITY JOURNAL; PROTEIN ENGINEERING; PROTEIN FOLDING; PROTEIN FUNCTION; PROTEIN LOCALIZATION; PROTEIN STRUCTURE; REVIEW;

ANIMALS; CARRIER PROTEINS; HUMANS; PROTEIN ENGINEERING; PROTEIN STRUCTURE, TERTIARY;

PROKARYOTA;

EID: 3142677981     PISSN: 00221759     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.jim.2004.04.006     Document Type: Review

References (156)

1. Abedi M.R., Caponigro G., Kamb A. Green fluorescent protein as a scaffold for intracellular presentation of peptides. Nucleic Acids Res. 26:1998;623
2. Andersson M., Rönnmark J., Areström I., Nygren P.-Å., Ahlborg N. Inclusion of a non-immunoglobulin binding protein in two-site ELISA for quantitation of human serum proteins without interference by heterophilic serum antibodies. J. Immunol. Methods. 283:2003;225
3. L domains dictates precisely the transition between diabodies and triabodies. Protein Eng. 12:1999;597
4. Auf der Maur A., Escher D., Barberis A. Antigen-independent selection of stable intracellular single-chain antibodies. FEBS Lett. 508:2001;407
5. Baggio R., Burgstaller P., Hale S.P., Putney A.R., Lane M., Lipovsek D., Wright M.C., Roberts R.W., Liu R., Szostak J.W., Wagner R.W. Identification of epitope-like consensus motifs using mRNA display. J. Mol. Recognit. 15:2002;126
6. Bai J., Sui J., Zhu R.Y., Tallarico A.S., Gennari F., Zhang D., Marasco W.A. Inhibition of Tat-mediated transactivation and HIV-1 replication by human anti-hCyclinT1 intrabodies. J. Biol. Chem. 278:2003;1433
7. Beste G., Schmidt F.S., Stibora T., Skerra A. Small antibody-like proteins with prescribed ligand specificities derived from the lipocalin fold. Proc. Natl. Acad. Sci. U. S. A. 96:1999;1898
8. Bianchi E., Venturini S., Pessi A., Tramontano A., Sollazzo M. High level expression and rational mutagenesis of a designed protein, the minibody. J. Mol. Biol. 236:1994;649
9. Bianchi E., Folgori A., Wallace A., Nicotra M., Acali S., Phalipon A., Barbato G., Bazzo R., Cortese R., Felici F., Pessi A. A conformationally homogeneous combinatorial peptide library. J. Mol. Biol. 247:1995;154
10. Binz H.K., Stumpp M.T., Forrer P., Amstutz P., Plückthun A. Designing repeat proteins: well-expressed, soluble and stable proteins from combinatorial libraries of consensus ankyrin repeat proteins. J. Mol. Biol. 332:2003;489
11. Binz H.K., Amstutz P., Kohl A., Stumpp M.T., Briand C., Forrer P., Grütter M.G., Plückthum A. High-affinity binders selected from designed ankyrin repeat protein libraries. Nat. Biotechnol. 22:2004;575
12. Bird R.E., Walker B.W. Single chain antibody variable regions. Trends Biotechnol. 9:1991;132
13. Blum J.H., Dove S.L., Hochschild A., Mekalanos J.J. Isolation of peptide aptamers that inhibit intracellular processes. Proc. Natl. Acad. Sci. U. S. A. 97:2000;2241
14. Bouri K., Feero W.G., Myerburg M.M., Wickham T.J., Kovesdi I., Hoffman E.P., Clemens P.R. Polylysine modification of adenoviral fiber protein enhances muscle cell transduction. Hum. Gene Ther. 10:1999;1633
15. Cai X., Garen A. A melanoma-specific VH antibody cloned from a fusion phage library of a vaccinated melanoma patient. Proc. Natl. Acad. Sci. U. S. A. 93:1996;6280
16. Carrier A., Ducancel F., Settiawan N.B., Cattolico L., Maillere B., Leonetti M., Drevet P., Menez A., Boulain J.C. Recombinant antibody-alkaline phosphatase conjugates for diagnosis of human IgGs: application to anti-HBsAg detection. J. Immunol. Methods. 181:1995;177
17. Cattaneo A., Biocca S. The selection of intracellular antibodies. Trends Biotechnol. 17:1999;115
18. Christmann A., Walter K., Wentzel A., Krätzner R., Kolmar H. The cystine knot of a squash-type protease inhibitor as a structural scaffold for Escherichia coli cell surface display of conformationally constrained peptides. Protein Eng. 12:1999;797
19. Clackson T., Wells J.A. In vitro selection from protein and peptide libraries. Trends Biotechnol. 12:1994;173
20. Colas P., Cohen B., Jessen T., Grishina I., McCoy J., Brent R. Genetic selection of peptide aptamers that recognize and inhibit cyclin-dependent kinase 2. Nature. 380:1996;548
21. Conrath K.E., Lauwereys M., Galleni M., Matagne A., Frere J.M., Kinne J., Wyns L., Muyldermans S. β-Lactamase inhibitors derived from single-domain antibody fragments elicited in the camelidae. Antimicrob. Agents Chemother. 45:2001;2807
22. Cowan S.W., Newcomer M.E., Jones T.A. Crystallographic refinement of human serum retinol-binding protein at 2 Å resolution. Prot. Struct. Funct. Genet. 8:1990;44
23. D'Alessio G. The evolution of monomeric and oligomeric βγ-type crystallines. Facts and hypotheses. Eur. J. Biochem. 269:2002;3122
24. Darmon A., Bar-Noy S., Ginsburg H., Cabantchik Z.I. Oriented reconstitution of red cell membrane proteins and assessment of their transmembrane disposition by immunoquenching of fluorescence. Biochim. Biophys. Acta. 817:1985;238
25. Davies J., Riechmann L. 'Camelising' human antibody fragments: NMR studies on VH domains. FEBS Lett. 339:1994;285
26. Davies J., Riechmann L. Antibody VH domains as small recognition units. Bio/Technology. 13:1995;475
27. Davies J., Riechmann L. Single antibody domains as small recognition units: design and in vitro antigen selection of camelized, human VH domains with improved protein stability. Protein Eng. 9:1996;531
28. Dennis M.S., Lazarus R.A. Kunitz domain inhibitors of tissue factor-factor VIIa. J. Biol. Chem. 269:1994;22129
29. Dooley H., Flajnik M.F., Porter A.J. Selection and characterization of naturally occurring single-domain (IgNAR) antibody fragments from immunized sharks by phage display. Mol. Immunol. 40:2003;25
30. Dowd C.S., Leavitt S., Babcock G., Godillot A.P., Van Ryk D., Canziani G.A., Sodroski J., Freire E., Chaiken I.M. β-Turn Phe in HIV-1 Env binding site of CD4 and CD4 mimetic miniprotein enhances Env binding affinity but is not required for activation of co-receptor/17b site. Biochemistry. 41:2002;7038
31. 2/alkaline phosphatase conjugate produced in Escherichia coli. Bio/Technology. 11:1993;601
32. Dumoulin M., Conrath K., Van Meirhaeghe A., Meersman F., Heremans K., Frenken L.G., Muyldermans S., Wyns L., Matagne A. Single-domain antibody fragments with high conformational stability. Protein Sci. 11:2002;500
33. Eklund M., Axelsson L., Uhlén M., Nygren P.Å. Anti-idiotypic protein domains selected from protein A-based affibody libraries. Proteins. 48:2002;454
34. Ewert S., Cambillau C., Conrath K., Plückthun A. Biophysical properties of camelid V(HH) domains compared to those of human V(H)3 domains. Biochemistry. 41:2002;3628
35. Fabbrizio E., Le C.L., Polanowska J., Kaczorek M., Lamb N., Brent R., Sardet C. Inhibition of mammalian cell proliferation by genetically selected peptide aptamers that functionally antagonize E2F activity. Oncogene. 18:1999;4357
36. Fiedler, U., Rudolph, R., 2001. Fabrication of beta-pleated sheet proteins with specific binding properties. International Patent Publication WO 01/04144.
37. Flower D.R. The lipocalin protein family: structure and function. Biochem. J. 318:1996;1
38. Gavin A.C., Bosche M., Krause R., Grandi P., Marzioch M., Bauer A., Schultz J., Rick J.M., Michon A.M., Cruciat C.M., Remor M., Hofert C., Schelder M., Brajenovic M., Ruffner H., Merino A., Klein K., Hudak M., Dickson D., Rudi T., Gnau V., Bauch A., Bastuck S., Huhse B., Leutwein C., Heurtier M.A., Copley R.R., Edelmann A., Querfurth E., Rybin V., Drewes G., Raida M., Bouwmeester T., Bork P., Seraphin B., Kuster B., Neubauer G., Superti-Furga G. Functional organization of the yeast proteome by systematic analysis of protein complexes. Nature. 415:2002;141
39. Glockshuber R., Malia M., Pfitzinger I., Plückthun A. A comparison of strategies to stabilize immunoglobin Fv-fragments. Biochemistry. 29:1990;1362
40. Goh Y.Y., Frecer V., Ho B., Ding J.L. Rational design of green fluorescent protein mutants as biosensor for bacterial endotoxin. Protein Eng. 15:2002;493
41. Götz M., Hess S., Beste G., Skerra A., Michel-Beyerle M.E. Ultrafast electron transfer in the complex between fluorescein and a cognate engineered lipocalin protein, a so-called anticalin. Biochemistry. 41:2002;4156
42. Griffiths A.D., Williams S.C., Hartley O., Tomlinson I.M., Waterhouse P., Crosby W.L., Kontermann R.E., Jones P.T., Low N.M., Allison T.J., Prospero T.D., Hoogenboom H.R., Nissim A., Cox J.P.L., Harrison J.L., Zaccolo M., Gherardi E., Winter G. Isolation of high affinity human antibodies directly from large synthetic repertoires. EMBO J. 13:1994;3245
43. Gunneriusson E., Nord K., Uhlén M., Nygren P.Å. Affinity maturation of a Taq DNA polymerase specific affibody by helix shuffling. Protein Eng. 12:1999;873
44. Hamers-Casterman C., Atarhouch T., Muyldermans S., Robinson G., Hamers C., Bajyana S.E., Bendahman N., Hamers R. Naturally occurring antibodies devoid of light chains. Nature. 363:1993;446
45. Hanes J., Jermutus L., Weber-Bornhauser S., Bosshard H.R., Plückthun A. Ribosome display efficiently selects and evolves high-affinity antibodies in vitro from immune libraries. Proc. Natl. Acad. Sci. U. S. A. 95:1998;14130
46. Hansson M., Ringdahl J., Robert A., Power U., Goetsch L., Nguyen T.N., Uhlén M., Stahl S., Nygren P.Å. An in vitro selected binding protein (affibody) shows conformation-dependent recognition of the respiratory syncytial virus (RSV) G protein. Immunotechnology. 4:1999;237
47. Henning P., Magnusson M.K., Gunneriusson E., Hong S.S., Boulanger P., Nygren P.Å., Lindholm L. Genetic modification of adenovirus 5 tropism by a novel class of ligands based on a three-helix bundle scaffold derived from staphylococcal protein A. Hum. Gene Ther. 13:2002;1427
48. Högbom M., Eklund M., Nygren P.Å., Nordlund P. Structural basis for recognition by an in vitro evolved affibody. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3191
49. Holt L.J., Herring C., Jespers L.S., Woolven B.P., Tomlinson I.M. Domain antibodies: proteins for therapy. Trends Biotechnol. 21:2003;484
50. Huber R., Schneider M., Mayr I., Muller R., Deutzmann R., Suter F., Zuber H., Falk H., Kayser H. Molecular structure of the bilin binding protein (BBP) from Pieris brassicae after refinement at 2.0 Å resolution. J. Mol. Biol. 198:1987;499
51. Hufton S.E., van Neer N., van den Beuken T., Desmet J., Sablon E., Hoogenboom H.R. Development and application of cytotoxic T lymphocyte-associated antigen 4 as a protein scaffold for the generation of novel binding ligands. FEBS Lett. 475:2000;225
52. Hunt K.K., Vorburger S.A. Tech.Sight. Gene therapy. Hurdles and hopes for cancer treatment. Science. 297:2002;415
53. Irving R.A., Coia G., Roberts A., Nuttall S.D., Hudson P.J. Ribosome display and affinity maturation: from antibodies to single V-domains and steps towards cancer therapeutics. J. Immunol. Methods. 248:2001;31
54. Karlstrom A., Nygren P.Å. Dual labeling of a binding protein allows for specific fluorescence detection of native protein. Anal. Biochem. 295:2001;22
55. Klevenz B., Butz K., Hoppe-Seyler F. Peptide aptamers: exchange of the thioredoxin-A scaffold by alternative platform proteins and its influence on target protein binding. Cell. Mol. Life Sci. 59:2002;1993
56. Klug A. Zinc finger peptides for the regulation of gene expression. J. Mol. Biol. 293:1999;215
57. Kobe B., Kajava A.V. When protein folding is simplified to protein coiling: the continuum of solenoid protein structures. Trends Biochem. Sci. 25:2000;509
58. Kohl A., Binz H.K., Forrer P., Stumpp M.T., Plückthun A., Grutter M.G. Designed to be stable: crystal structure of a consensus ankyrin repeat protein. Proc. Natl. Acad. Sci. U. S. A. 100:2003;1700
59. Koide A., Bailey C.W., Huang X., Koide S. The fibronectin type III domain as a scaffold for novel binding proteins. J. Mol. Biol. 284:1998;1141
60. Koide A., Abbatiello S., Rothgery L., Koide S. Probing protein conformational changes in living cells by using designer binding proteins: application to the estrogen receptor. Proc. Natl. Acad. Sci. U. S. A. 99:2002;1253
61. König T., Skerra A. Use of an albumin-binding domain for the selective immobilisation of recombinant capture antibody fragments on ELISA plates. J. Immunol. Methods. 218:1998;73
62. Korndörfer I.P., Beste G., Skerra A. Crystallographic analysis of an "anticalin" with tailored specificity for fluorescein reveals high structural plasticity of the lipocalin loop region. Proteins. 53:2003;121
63. Korndörfer I.P., Schlehuber S., Skerra A. Structural mechanism of specific ligand recognition by a lipocalin tailored for the complexation of digoxigenin. J. Mol. Biol. 330:2003;385
64. Kraulis P.J. MolScript - a program to produce both detailed and schematic plots of protein structures. J. Appl. Crystallogr. 24:1991;946
65. Kristensen P., Winter G. Proteolytic selection for protein folding using filamentous bacteriophages. Fold. Des. 3:1998;321
66. Lauwereys M., Ghahroudi M.A., Desmyter A., Kinne J., Hölzer W., De G.E., Wyns L., Muyldermans S. Potent enzyme inhibitors derived from dromedary heavy-chain antibodies. EMBO J. 17:1998;3512
67. LaVallie E.R., DiBlasio E.A., Kovacic S., Grant K.L., Schendel P.F., McCoy J.M. A thioredoxin gene fusion expression system that circumvents inclusion body formation in the E. coli cytoplasm. Bio/Technology. 11:1993;187
68. Legendre D., Vucic B., Hougardy V., Girboux A.L., Henrioul C., Van Haute J., Soumillion P., Fastrez J. TEM-1 β-lactamase as a scaffold for protein recognition and assay. Protein Sci. 11:2002;1506
69. Lehtio J., Teeri T.T., Nygren P.A. Alpha-amylase inhibitors selected from a combinatorial library of a cellulose binding domain scaffold. Proteins. 41:2000;316
70. Le Nguyen D.L., Heitz A., Chiche L., Castro B., Boigegrain R.A., Favel A., Coletti-Previero M.A. Molecular recognition between serine proteases and new bioactive microproteins with a knotted structure. Biochimie. 72:1990;431
71. Li R., Hoess R.H., Bennett J.S., DeGrado W.F. Use of phage display to probe the evolution of binding specificity and affinity in integrins. Protein Eng. 16:2003;65
72. Lin H., Cornish V.W. Screening and selection methods for large-scale analysis of protein function. Angew. Chem., Int. Ed. Engl. 41:2002;4402
73. Lu Z., Murray K.S., Van C.V., LaVallie E.R., Stahl M.L., McCoy J.M. Expression of thioredoxin random peptide libraries on the Escherichia coli cell surface as functional fusions to flagellin: a system designed for exploring protein-protein interactions. Bio/Technology. 13:1995;366
74. Magnusson M.K., Hong S.S., Henning P., Boulanger P., Lindholm L. Genetic retargeting of adenovirus vectors: functionality of targeting ligands and their influence on virus viability. J. Gene Med. 4:2002;356
75. Markland W., Ley A.C., Ladner R.C. Iterative optimization of high-affinity protease inhibitors using phage display: 2. Plasma kallikrein and thrombin. Biochemistry. 35:1996;8058
76. Markland W., Ley A.C., Lee S.W., Ladner R.C. Iterative optimization of high-affinity protease inhibitors using phage display: 1. Plasmin. Biochemistry. 35:1996;8045
77. Martin A., Schmid F.X. Evolutionary stabilization of the gene-3-protein of phage fd reveals the principles that govern the thermodynamic stability of two-domain proteins. J. Mol. Biol. 328:2003;863
78. Martin F., Toniatti C., Salvati A.L., Venturini S., Ciliberto G., Cortese R., Sollazzo M. The affinity-selection of a minibody polypeptide inhibitor of human interleukin-6. EMBO J. 13:1994;5303
79. Martin F., Volpari C., Steinkühler C., Dimasi N., Brunetti M., Biasiol G., Altamura S., Cortese R., De F.R., Sollazzo M. Affinity selection of a camelized VH domain antibody inhibitor of hepatitis C virus NS3 protease. Protein Eng. 10:1997;607
80. Martin F., Steinkühler C., Brunetti M., Pessi A., Cortese R., De F.R., Sollazzo M. A loop-mimetic inhibitor of the HCV-NS3 protease derived from a minibody. Protein Eng. 12:1999;1005
81. Masat L., Wabl M., Johnson J.P. A simpler sort of antibody. Proc. Natl. Acad. Sci. U. S. A. 91:1994;893
82. McConnell S.J., Hoess R.H. Tendamistat as a scaffold for conformationally constrained phage peptide libraries. J. Mol. Biol. 250:1995;460
83. McCreery T. Digoxigenin labeling. Mol. Biotechnol. 7:1997;121
84. Mercader J.V., Skerra A. Generation of anticalins with specificity for a nonsymmetric phthalic acid ester. Anal. Biochem. 308:2002;269
85. Monaco H.L., Rizzi M., Coda A. Structure of a complex of two plasma proteins: transthyretin and retinol-binding protein. Science. 268:1995;1039
86. Mosavi L.K., Minor D.L. Jr., Peng Z.Y. Consensus-derived structural determinants of the ankyrin repeat motif. Proc. Natl. Acad. Sci. U. S. A. 99:2002;16029
87. Müller H.N., Skerra A. Grafting of a high-affinity Zn(II)-binding site on the β-barrel of retinol-binding protein results in enhanced folding stability and enables simplified purification. Biochemistry. 33:1994;14126
88. Muyldermans S., Cambillau C., Wyns L. Recognition of antigens by single-domain antibody fragments: the superfluous luxury of paired domains. Trends Biochem. Sci. 26:2001;230
89. Newcomer M.E., Jones T.A., Åqvist J., Sundelin J., Eriksson U., Rask L., Peterson P.A. The three-dimensional structure of retinol-binding protein. EMBO J. 3:1984;1451
90. Nilsson B., Moks T., Jansson B., Abrahmsen L., Elmblad A., Holmgren E., Henrichson C., Jones T.A., Uhlén M. A synthetic IgG-binding domain based on staphylococcal protein A. Protein Eng. 1:1987;107
91. Nord K., Nilsson J., Nilsson B., Uhlén M., Nygren P.Å. A combinatorial library of an alpha-helical bacterial receptor domain. Protein Eng. 8:1995;601
92. Nord K., Gunneriusson E., Ringdahl J., Stahl S., Uhlén M., Nygren P.Å. Binding proteins selected from combinatorial libraries of an alpha-helical bacterial receptor domain. Nat. Biotechnol. 15:1997;772
93. M and Taq DNA polymerase. J. Biotechnol. 80:2000;45
94. Nord K., Nord O., Uhlén M., Kelley B., Ljungqvist C., Nygren P.Å. Recombinant human factor VIII-specific affinity ligands selected from phage-displayed combinatorial libraries of protein A. Eur. J. Biochem. 268:2001;4269
95. Norman T.C., Smith D.L., Sorger P.K., Drees B.L., O'Rourke S.M., Hughes T.R., Roberts C.J., Friend S.H., Fields S., Murray A.W. Genetic selection of peptide inhibitors of biological pathways. Science. 285:1999;591
96. Norton R.S., Pallaghy P.K. The cystine knot structure of ion channel toxins and related polypeptides. Toxicon. 36:1998;1573
97. Nourry C., Grant S.G., Borg J.P. PDZ domain proteins: plug and play! Sci. STKE. 2003;RE7
98. Nuttall S.D., Rousch M.J.M., Irving R.A., Hufton S.E., Hoogenboom H.R., Hudson P.J. Design and expression of soluble CTLA-4 variable domain as a scaffold for the display of functional polypeptides. Prot. Struct. Funct. Genet. 36:1999;217
99. Nuttall S.D., Krishnan U.V., Hattarki M., De Gori R., Irving R.A., Hudson P.J. Isolation of the new antigen receptor from wobbegong sharks, and use as a scaffold for the display of protein loop libraries. Mol. Immunol. 38:2001;313
100. Nuttall S.D., Krishnan U.V., Doughty L., Pearson K., Ryan M.T., Hoogenraad N.J., Hattarki M., Carmichael J.A., Irving R.A., Hudson P.J. Isolation and characterization of an IgNAR variable domain specific for the human mitochondrial translocase receptor Tom70. Eur. J. Biochem. 270:2003;3543
101. Nygren P.Å., Uhlén M. Scaffolds for engineering novel binding sites in proteins. Curr. Opin. Struct. Biol. 7:1997;463
102. Padlan E.A. Anatomy of the antibody molecule. Mol. Immunol. 31:1994;169
103. Pedersen J.S., Otzen D.E., Kristensen P. Directed evolution of barnase stability using proteolytic selection. J. Mol. Biol. 323:2002;115
104. Peelle B., Lorens J., Li W., Bogenberger J., Payan D.G., Anderson D.C. Intracellular protein scaffold-mediated display of random peptide libraries for phenotypic screens in mammalian cells. Chem. Biol. 8:2001;521
105. Pessi A., Bianchi E., Crameri A., Venturini S., Tramontano A., Sollazzo M. A designed metal-binding protein with a novel fold. Nature. 362:1993;367
106. Proba K., Worn A., Honegger A., Plückthun A. Antibody scFv fragments without disulfide bonds made by molecular evolution. J. Mol. Biol. 275:1998;245
107. Ranganathan R., Ross E.M. PDZ domain proteins: scaffolds for signaling complexes. Curr. Biol. 7:1997;R770
108. Reiter Y., Schuck P., Boyd L.F., Plaksin D. An antibody single-domain phage display library of a native heavy chain variable region: isolation of functional single-domain VH molecules with a unique interface. J. Mol. Biol. 290:1999;685
109. Riechmann L. Rearrangement of the former VL interface in the solution structure of a camelised, single antibody VH domain. J. Mol. Biol. 259:1996;957
110. Rigaut G., Shevchenko A., Rutz B., Wilm M., Mann M., Seraphin B. A generic protein purification method for protein complex characterization and proteome exploration. Nat. Biotechnol. 17:1999;1030
111. Roberts R.W., Ja W.W. In vitro selection of nucleic acids and proteins: what are we learning? Curr. Opin. Struct. Biol. 9:1999;521
112. Roberts B.L., Markland W., Ley A.C., Kent R.B., White D.W., Guterman S.K., Ladner R.C. Directed evolution of a protein: selection of potent neutrophil elastase inhibitors displayed on M13 fusion phage. Proc. Natl. Acad. Sci. U. S. A. 89:1992;2429
113. Roberts B.L., Markland W., Siranosian K., Saxena M.J., Guterman S.K., Ladner R.C. Protease inhibitor display M13 phage: selection of high-affinity neutrophil elastase inhibitors. Gene. 121:1992;9
114. Rönnmark J., Gronlund H., Uhlén M., Nygren P.Å. Human immunoglobulin A (IgA)-specific ligands from combinatorial engineering of protein A. Eur. J. Biochem. 269:2002;2647
115. Rönnmark J., Hansson M., Nguyen T., Uhlén M., Robert A., Stahl S., Nygren P.Å. Construction and characterization of affibody-Fc chimeras produced in Escherichia coli. J. Immunol. Methods. 261:2002;199
116. Rönnmark J., Kampf C., Asplund A., Höidén-Guthenberg I., Wester K., Pontén F., Uhlén M., Nygren P.-Å. Affibody-β-galactosidase immunoconjugates produced as soluble fusion proteins in the Escherichia coli cytosol. J. Immunol. Methods. 281:2003;149
117. Röttgen P., Collins J. A human pancreatic secretory trypsin inhibitor presenting a hypervariable highly constrained epitope via monovalent phagemid display. Gene. 164:1995;243
118. Sandström K., Xu Z., Forsberg G., Nygren P.Å. Inhibition of the CD28-CD80 co-stimulation signal by a CD28-binding affibody ligand developed by combinatorial protein engineering. Protein Eng. 16:2003;691
119. Sblattero D., Bradbury A. Exploiting recombination in single bacteria to make large phage antibody libraries. Nat. Biotechnol. 18:2000;75
120. Schlehuber S., Skerra A. Duocalins: engineered ligand-binding proteins with dual specificity derived from the lipocalin fold. Biol. Chem. 382:2001;1335
121. Schlehuber S., Skerra A. Tuning ligand affinity, specificity, and folding stability of an engineered lipocalin variant - a so-called 'anticalin' - using a molecular random approach. Biophys. Chem. 96:2002;213
122. Schlehuber S., Beste G., Skerra A. A novel type of receptor protein, based on the lipocalin scaffold, with specificity for digoxigenin. J. Mol. Biol. 297:2000;1105
123. Schmidt A.M., Müller H.N., Skerra A. A Zn(II)-binding site engineered into retinol-binding protein exhibits metal-ion specificity and allows highly efficient affinity purification with a newly designed metal ligand. Chem. Biol. 3:1996;645
124. Schneider S., Buchert M., Georgiev O., Catimel B., Halford M., Stacker S.A., Baechi T., Moelling K., Hovens C.M. Mutagenesis and selection of PDZ domains that bind new protein targets. Nat. Biotechnol. 17:1999;170
125. Segal D.J., Dreier B., Beerli R.R., Barbas C.F. 3rd Toward controlling gene expression at will: selection and design of zinc finger domains recognizing each of the 5′-GNN-3′ DNA target sequences. Proc. Natl. Acad. Sci. U. S. A. 96:1999;2758
126. Segal D.J., Beerli R.R., Blancafort P., Dreier B., Effertz K., Huber A., Koksch B., Lund C.V., Magnenat L., Valente D., Barbas C.F. 3rd Evaluation of a modular strategy for the construction of novel polydactyl zinc finger DNA-binding proteins. Biochemistry. 42:2003;2137
127. Sieber V., Plückthun A., Schmid F.X. Selecting proteins with improved stability by a phage-based method. Nat. Biotechnol. 16:1998;955
128. Skerra A. Engineered protein scaffolds for molecular recognition. J. Mol. Recognit. 13:2000;167
129. Skerra A. Lipocalins as a scaffold. Biochim. Biophys. Acta. 1482:2000;337
130. Skerra A. Imitating the humoral immune response. Curr. Opin. Chem. Biol. 7:2003;683
131. Skerra A., Plückthun A. Assembly of a functional immunoglobulin Fv fragment in Escherichia coli. Science. 240:1988;1038
132. Smith G.P., Petrenko V.A. Phage display. Chem. Rev. 97:1997;391
133. Smith G.P., Patel S.U., Windass J.D., Thornton J.M., Winter G., Griffiths A.D. Small binding proteins selected from a combinatorial repertoire of knottins displayed on phage. J. Mol. Biol. 277:1998;317
134. Söderlind E., Strandberg L., Jirholt P., Kobayashi N., Alexeiva V., Aberg A.M., Nilsson A., Jansson B., Ohlin M., Wingren C., Danielsson L., Carlsson R., Borrebaeck C.A. Recombining germline-derived CDR sequences for creating diverse single-framework antibody libraries. Nat. Biotechnol. 18:2000;852
135. Spinelli S., Tegoni M., Frenken L., van Vliet C., Cambillau C. Lateral recognition of a dye hapten by a llama VHH domain. J. Mol. Biol. 311:2001;123
136. Stevens F.J., Solomon A., Schiffer M. Bence Jones proteins: a powerful tool for the fundamental study of protein chemistry and pathophysiology. Biochemistry. 30:1991;6803
137. Stoop A.A., Craik C.S. Engineering of a macromolecular scaffold to develop specific protease inhibitors. Nat. Biotechnol. 21:2003;1063
138. Stumpp M.T., Forrer P., Binz H.K., Plückthun A. Designing repeat proteins: modular leucine-rich repeat protein libraries based on the mammalian ribonuclease inhibitor family. J. Mol. Biol. 332:2003;471
139. Tanaka T., Rabbitts T.H. Intrabodies based on intracellular capture frameworks that bind the RAS protein with high affinity and impair oncogenic transformation. EMBO J. 22:2003;1025
140. Tanaka T., Chung G.T., Forster A., Lobato M.N., Rabbitts T.H. De novo production of diverse intracellular antibody libraries. Nucleic Acids Res. 31:2003;e23
141. Tomme P., Boraston A., McLean B., Kormos J., Creagh A.L., Sturch K., Gilkes N.R., Haynes C.A., Warren R.A., Kilburn D.G. Characterization and affinity applications of cellulose-binding domains. J. Chromatogr., B, Biomed. Sci. Appl. 715:1998;283
142. Uhlén M., Forsberg G., Moks T., Hartmanis M., Nilsson B. Fusion proteins in biotechnology. Curr. Opin. Biotechnol. 3:1992;363
143. Visintin M., Settanni G., Maritan A., Graziosi S., Marks J.D., Cattaneo A. The intracellular antibody capture technology (IACT): towards a consensus sequence for intracellular antibodies. J. Mol. Biol. 317:2002;73
144. Vita C., Roumestand C., Toma F., Menez A. Scorpion toxins as natural scaffolds for protein engineering. Proc. Natl. Acad. Sci. U. S. A. 92:1995;6404
145. Vita C., Vizzavona J., Drakopoulou E., Zinn-Justin S., Gilquin B., Menez A. Novel miniproteins engineered by the transfer of active sites to small natural scaffolds. Biopolymers. 47:1998;93
146. Vita C., Drakopoulou E., Vizzavona J., Rochette S., Martin L., Menez A., Roumestand C., Yang Y.S., Ylisastigui L., Benjouad A., Gluckman J.C. Rational engineering of a miniprotein that reproduces the core of the CD4 site interacting with HIV-1 envelope glycoprotein. Proc. Natl. Acad. Sci. U. S. A. 96:1999;13091
147. Vogt M., Skerra A. Construction of an artificial receptor protein ("anticalin") based on the human apolipoprotein D. Chem. Biol. Chem. 5:2004;191
148. Vranken W., Tolkatchev D., Xu P., Tanha J., Chen Z., Narang S., Ni F. Solution structure of a llama single-domain antibody with hydrophobic residues typical of the VH/VL interface. Biochemistry. 41:2002;8570
149. Wahlberg E., Lendel C., Helgstrand M., Allard P., Dincbas-Renqvist V., Hedqvist A., Berglund H., Nygren P.Å., Hard T. An affibody in complex with a target protein: structure and coupled folding. Proc. Natl. Acad. Sci. U. S. A. 100:2003;3185
150. Wang C.I., Yang Q., Craik C.S. Isolation of a high affinity inhibitor of urokinase-type plasminogen activator by phage display of ecotin. J. Biol. Chem. 270:1995;12250
151. Wentzel A., Christmann A., Adams T., Kolmar H. Display of passenger proteins on the surface of Escherichia coli K-12 by the enterohemorrhagic E. coli intimin EaeA. J. Bacteriol. 183:2001;7273
152. Wernerus H., Lehtio J., Teeri T., Nygren P.Å., Stahl S. Generation of metal-binding staphylococci through surface display of combinatorially engineered cellulose-binding domains. Appl. Environ. Microbiol. 67:2001;4678
153. Wickham T.J., Segal D.M., Roelvink P.W., Carrion M.E., Lizonova A., Lee G.M., Kovesdi I. Targeted adenovirus gene transfer to endothelial and smooth muscle cells by using bispecific antibodies. J. Virol. 70:1996;6831
154. Wirtz P., Steipe B. Intrabody construction and expression: III. Engineering hyperstable V(H) domains. Protein Sci. 8:1999;2245
155. Xu L., Aha P., Gu K., Kuimelis R.G., Kurz M., Lam T., Lim A.C., Liu H., Lohse P.A., Sun L., Weng S., Wagner R.W., Lipovsek D. Directed evolution of high-affinity antibody mimics using mRNA display. Chem. Biol. 9:2002;933
156. Yau K.Y., Groves M.A., Li S., Sheedy C., Lee H., Tanha J., MacKenzie C.R., Jermutus L., Hall J.C. Selection of hapten-specific single-domain antibodies from a non-immunized llama ribosome display library. J. Immunol. Methods. 281:2003;161